相关实验视频

Updated: Jan 8, 2026

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods

Published on: September 10, 2018

在家治疗低风险的妊娠 trofhoblastic 新生病,使用8天的甲状腺/叶酸

Izildinha Maesta¹, Valdete Aparecida Ribeiro Silva², Roberto Antonio Araújo Costa³

¹Botucatu Trophoblastic Disease Center, São Paulo State University (UNESP), Medical School, Av. Professor Mário Rubens Guimarães Montenegro, s/n°, Botucatu, SP 18618-687, Brazil; Postgraduation Program in Tocogynecology, São Paulo State University (UNESP), Medical School, Av. Professor Mário Rubens Guimarães Montenegro, s/n°, Botucatu, SP 18618-687, Brazil.

Gynecologic oncology

|December 11, 2025

概括

针对低风险妊娠 trofhoblastic neoplasia (GTN) 的家庭化疗,使用8天的甲基酸/folinic 酸 (MTX/FA),与医院治疗一样有效和安全. 这种方法提供了类似的缓解率和存活率,提供了更加以患者为中心的选择.

科学领域:

妇科妇科妇科妇科
在瘤学瘤学.
药理学药理学是指药理学的学科.

背景情况:

孕期 trofhoblastic瘤 (GTN) 需要有效的化疗.
低风险GTN管理传统上发生在医院.
家庭化疗有可能增加患者的便利性.

研究的目的:

为了比较家庭化疗与医院化疗的有效性和安全性.
评估在不同环境下对低风险GTN进行为期8天的甲醇/叶酸 (MTX/FA) 治疗.

主要方法:

对141名患有低风险GTN,接受一线MTX/FA的患者进行了回顾性研究.
在家 (巴西) 和医院 (美国) 的治疗中心之间的比较.
分析治疗前的hCG,FIGO分期,缓解率,毒性和存活率.

主要成果:

持续完全缓解率没有显著差异 (72.5%的家庭与78.7%的医院).
在不同环境中,耐药性和与毒性相关的治疗失败率相似.
家庭治疗显示了更长的缓解时间 (57 vs. 41天) 并需要更多的周期.

结论:

针对低风险GTN的家庭MTX/FA化疗是可行的,其结果与医院治疗相似.
这两个设置都显示了类似的缓解率,毒性和存活率.
家庭治疗为GTN护理提供了一个灵活,以患者为中心的替代方案.

关键词:

怀孕期的 trofhoblastic 新生病.在家进行治疗.低风险的低风险的甲基甲酸二醇的使用方法

更多相关视频

In Vitro Assays to Evaluate the Migration, Invasion, and Proliferation of Immortalized Human First-trimester Trophoblast Cell Lines

In Vitro Assays to Evaluate the Migration, Invasion, and Proliferation of Immortalized Human First-trimester Trophoblast Cell Lines

Published on: March 5, 2019

Protocol for the Direct Conversion of Murine Embryonic Fibroblasts into Trophoblast Stem Cells

Protocol for the Direct Conversion of Murine Embryonic Fibroblasts into Trophoblast Stem Cells

Published on: July 25, 2016

相关概念视频

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.